GO:1901568 fatty acid derivative metabolic process: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1901568 (fatty acid derivative metabolic process) describes the chemical reactions and pathways involving fatty acid derivatives, a broad class of molecules that includes acyl-carnitines, acyl-CoAs, eicosanoids, and other lipid species.
• Mitochondrial beta-oxidation of saturated fatty acids is a core route within this process, generating acetyl-CoA and reducing equivalents for energy production.
• Carnitine and carnitine palmitoyltransferase 1 (CPT1) are essential for shuttling long-chain fatty acids into mitochondria for oxidation.
• Fatty acid derivative metabolism intersects with bile acid metabolism and is implicated in non-alcoholic fatty liver disease (NAFLD).
• Gut microbial consumption of host-accessible carbohydrates can influence fatty acid derivative metabolism and body mass regulation.
• Pyruvate-supported flux through medium-chain ketothiolase promotes mitochondrial lipid tolerance in cardiac and skeletal muscle.
Description
Fatty acid derivative metabolic process (GO:1901568) is a biological process ontology term that encompasses the chemical reactions and pathways involving fatty acid derivatives. Fatty acid derivatives are molecules derived from fatty acids through enzymatic modifications, including acyl-carnitines, acyl-CoAs, eicosanoids, and other lipid species that participate in energy metabolism, signaling, and membrane biology. This process is fundamental to cellular energy homeostasis, as it includes the mitochondrial beta-oxidation of saturated fatty acids, which generates acetyl-CoA and reducing equivalents for the electron transport chain. Researchers study GO:1901568 to understand how cells and tissues adapt to nutrient availability, how metabolic dysfunction contributes to diseases such as non-alcoholic fatty liver disease (NAFLD), and how interventions like carnitine supplementation or dietary modulation can alter metabolic flux. The process is also critical in muscle bioenergetics, where carnitine availability and carnitine palmitoyltransferase 1 (CPT1) activity regulate fatty acid oxidation rates. Recent work has highlighted the importance of mitochondrial lipid tolerance and the role of pyruvate-supported flux through medium-chain ketothiolase in maintaining cardiac and skeletal muscle function.
fatty acid derivative metabolic process At A Glance
| GO ID | GO:1901568 |
|---|---|
| GO term | fatty acid derivative metabolic process |
| Ontology | biological_process |
| Synonym | fatty acid derivative metabolism |
| Major function | Chemical reactions and pathways involving fatty acid derivatives, including acyl-carnitines, acyl-CoAs, and related lipid molecules |
| Related pathways | Mitochondrial beta-oxidation, carnitine shuttle, bile acid metabolism, eicosanoid synthesis |
| Key enzymes | Carnitine palmitoyltransferase 1 (CPT1), medium-chain ketothiolase, and other beta-oxidation enzymes |
| Disease relevance | Non-alcoholic fatty liver disease, metabolic disorders, muscle bioenergetics defects |
What Is GO:1901568?
According to the Gene Ontology, GO:1901568 (fatty acid derivative metabolic process) is defined as the chemical reactions and pathways involving fatty acid derivatives. This term captures all enzymatic steps that convert, modify, or degrade molecules derived from fatty acids, including but not limited to acyl-carnitines, acyl-CoAs, and oxidized lipid species. It is a broad biological process term that serves as a parent for more specific pathways such as fatty acid beta-oxidation, fatty acid derivative biosynthesis, and fatty acid derivative catabolism.
Why Is fatty acid derivative metabolic process Important in Cell Biology?
Understanding fatty acid derivative metabolic process is essential because it sits at the intersection of energy production, metabolic regulation, and disease pathogenesis. Defects in this process contribute to metabolic disorders such as non-alcoholic fatty liver disease, and its modulation by diet or pharmacological agents can influence whole-body energy balance. In muscle, carnitine availability and CPT1 activity are rate-limiting for fatty acid oxidation, making this process central to exercise performance and metabolic health. Moreover, mitochondrial lipid tolerance mechanisms involving pyruvate-supported flux through medium-chain ketothiolase are critical for maintaining cardiac and skeletal muscle function under lipid overload.
• Provides acetyl-CoA and reducing equivalents for the electron transport chain and ATP production.
• Regulates energy homeostasis in tissues such as skeletal muscle, heart, and liver.
• Carnitine and CPT1 are essential for mitochondrial import of long-chain fatty acids.
• Dysregulation is linked to non-alcoholic fatty liver disease (NAFLD).
• Gut microbial metabolism of host-accessible carbohydrates can influence fatty acid derivative metabolism and body mass.
• Pyruvate-supported flux through medium-chain ketothiolase promotes mitochondrial lipid tolerance.
• Serves as a target for nutritional and pharmacological interventions, including carnitine supplementation.
• Relevant to exercise physiology and muscle bioenergetics.
• Implicated in metabolic flexibility and substrate switching in cardiac and skeletal muscle.
• Provides a framework for understanding lipid-derived signaling molecules and their turnover.
What Happens During fatty acid derivative metabolic process?
Fatty acid activation and carnitine shuttle
In simple terms: Fatty acids are first activated and then shuttled into mitochondria with the help of carnitine.
Long-chain fatty acids are activated to acyl-CoA and then converted to acyl-carnitines by carnitine palmitoyltransferase 1 (CPT1) for transport into mitochondria. Carnitine is essential for this shuttle, and its availability can limit fatty acid oxidation rates in muscle. CPT1 facilitates fatty acid oxidation in a non-cell-autonomous manner, highlighting intercellular coordination.
Mitochondrial beta-oxidation
In simple terms: Inside mitochondria, fatty acids are broken down step by step to produce energy.
Mitochondrial beta-oxidation of saturated fatty acids involves cycles of dehydrogenation, hydration, thiolysis, and thiolytic cleavage, generating acetyl-CoA and reducing equivalents (NADH, FADH2). This pathway is a core component of GO:1901568 and is regulated by substrate availability and energy demand.
Medium-chain ketothiolase and lipid tolerance
In simple terms: A specific enzyme step helps mitochondria handle excess lipids without stress.
Pyruvate-supported flux through medium-chain ketothiolase promotes mitochondrial lipid tolerance in cardiac and skeletal muscles, linking carbohydrate and lipid metabolism. This mechanism helps prevent lipotoxicity under conditions of lipid overload.
Integration with bile acid and gut microbial metabolism
In simple terms: Fatty acid derivatives also interact with bile acids and gut bacteria.
Hyperoside modulates bile acid and fatty acid metabolism, presenting a potentially promising treatment for non-alcoholic fatty liver disease. Additionally, acetylated cellulose suppresses body mass gain through gut commensals consuming host-accessible carbohydrates, which can influence fatty acid derivative metabolism.
Key Genes Involved in GO:1901568 fatty acid derivative metabolic process
The following genes and proteins are key players in fatty acid derivative metabolic process, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CPT1A | Carnitine palmitoyltransferase 1, rate-limiting for mitochondrial fatty acid import | Target for modulating fatty acid oxidation in muscle and liver |
| CPT1B | Muscle isoform of CPT1, facilitates fatty acid oxidation | Studied in cardiac and skeletal muscle energy metabolism |
| CPT2 | Carnitine palmitoyltransferase 2, inner mitochondrial membrane enzyme | Defects cause fatty acid oxidation disorders |
| ACADM | Medium-chain acyl-CoA dehydrogenase, beta-oxidation enzyme | Deficiency leads to medium-chain acyl-CoA dehydrogenase deficiency |
| ACADVL | Very long-chain acyl-CoA dehydrogenase | Defects cause VLCAD deficiency |
| HADHA | Trifunctional protein subunit, beta-oxidation | Mutations cause mitochondrial trifunctional protein deficiency |
| HADHB | Trifunctional protein subunit, beta-oxidation | Mutations cause mitochondrial trifunctional protein deficiency |
| SLC25A20 | Carnitine-acylcarnitine translocase | Defects impair carnitine shuttle |
| PPARA | Peroxisome proliferator-activated receptor alpha, regulates lipid metabolism genes | Target for dyslipidemia and NAFLD |
| PPARG | Peroxisome proliferator-activated receptor gamma, adipocyte lipid metabolism | Target for insulin sensitizers |
| FABP1 | Liver fatty acid-binding protein | Involved in hepatic lipid trafficking |
| ACOX1 | Peroxisomal acyl-CoA oxidase 1 | Peroxisomal beta-oxidation |
| CROT | Carnitine O-octanoyltransferase | Peroxisomal fatty acid oxidation |
| SLC22A5 | Carnitine transporter OCTN2 | Carnitine uptake deficiency |
| BDH1 | 3-hydroxybutyrate dehydrogenase, ketone body metabolism | Links fatty acid oxidation to ketogenesis |
| HMGCS2 | HMG-CoA synthase 2, ketogenesis | Ketone body synthesis from acetyl-CoA |
| ACAT1 | Acetyl-CoA acetyltransferase 1, ketone body utilization | Ketone body metabolism |
How Is fatty acid derivative metabolic process Regulated?
Fatty acid derivative metabolic process is regulated at multiple levels, including substrate availability, hormonal signals, and transcriptional control. Carnitine availability and CPT1 activity are key regulatory nodes; CPT1 is inhibited by malonyl-CoA, linking fatty acid oxidation to glucose metabolism. Pyruvate-supported flux through medium-chain ketothiolase provides a mechanism for mitochondrial lipid tolerance, integrating carbohydrate and lipid fluxes. Additionally, bile acid and fatty acid metabolism can be modulated by compounds such as hyperoside, which may affect NAFLD progression. Gut microbial composition and dietary fiber intake can also influence fatty acid derivative metabolism and body mass regulation.
fatty acid derivative metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CPT1A | Fatty acid oxidation disorders, NAFLD | Liver-specific knockout mouse |
| CPT2 | CPT2 deficiency, rhabdomyolysis | Knockout cell model |
| ACADM | MCAD deficiency | Patient-derived fibroblasts |
| PPARA | Dyslipidemia, NAFLD | Overexpression in hepatocytes |
| SLC22A5 | Primary carnitine deficiency | Knockout zebrafish |
Non-alcoholic fatty liver disease (NAFLD)
Dysregulation of fatty acid derivative metabolic process contributes to hepatic lipid accumulation and NAFLD. Hyperoside has been shown to modulate bile acid and fatty acid metabolism, presenting a potentially promising treatment for NAFLD. Targeting this process may improve liver steatosis and metabolic parameters.
Muscle bioenergetics and exercise performance
Carnitine availability and CPT1 activity are critical for muscle fatty acid oxidation. Carnitine supplementation may improve physical exercise performance by enhancing fatty acid derivative metabolic process. CPT1 facilitates fatty acid oxidation in a non-cell-autonomous manner, which is relevant for muscle energy homeostasis.
Metabolic disorders and lipid tolerance
Impaired mitochondrial lipid tolerance, involving medium-chain ketothiolase flux, can lead to lipotoxicity in cardiac and skeletal muscles. This links fatty acid derivative metabolic process to metabolic syndrome and related disorders.
From fatty acid derivative metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CPT1A knockout alter fatty acid oxidation? | CRISPR knockout in HepG2 or C2C12 cells |
| Does a point mutation in ACADM affect enzyme activity? | CRISPR point mutation in patient fibroblasts |
| Can knock-in of a tagged CPT1A reveal localization? | CRISPR knock-in of GFP tag in HeLa cells |
| Does overexpression of PPARA increase lipid metabolism genes? | Lentiviral overexpression in primary hepatocytes |
| Does carnitine supplementation rescue CPT1 deficiency? | Knockout mouse model with dietary intervention |
| Does gut microbiota modulate fatty acid derivatives? | Germ-free mouse colonization |
How to Study the fatty acid derivative metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Seahorse assay | Oxygen consumption rate, fatty acid oxidation | Mitochondrial function in cells |
| LC-MS lipidomics | Acyl-carnitine and fatty acid derivative levels | NAFLD models |
| RNA-seq | Gene expression changes | Pathway analysis |
| CRISPR knockout screen | Gene essentiality for lipid tolerance | Cardiac and skeletal muscle cells |
| Western blot | Protein levels of CPT1, ACADM | Validation of knockout |
| Immunofluorescence | Subcellular localization of CPT1 | Mitochondrial import studies |
| Carnitine uptake assay | Carnitine transport activity | SLC22A5 function |
| Beta-oxidation assay | Radioactive or fluorescent fatty acid oxidation | Enzyme deficiency diagnosis |
Metabolic flux analysis
Metabolic flux analysis using stable isotopes can quantify fatty acid oxidation rates and identify bottlenecks in fatty acid derivative metabolic process. This method is typically applied in cell and tissue extracts to measure acetyl-CoA production and TCA cycle activity.
Transcriptomics and proteomics
RNA-seq and proteomics can reveal changes in expression of genes involved in fatty acid derivative metabolic process, such as CPT1A, ACADM, and PPARA, under different conditions. These approaches are useful for identifying regulatory networks and biomarkers.
CRISPR screening
Genome-wide CRISPR knockout screens can identify genes essential for fatty acid derivative metabolic process, including those affecting lipid tolerance and energy homeostasis. Hits can be validated with targeted knockouts.
Imaging and lipidomics
Fluorescence imaging of lipid droplets and mass spectrometry-based lipidomics can measure changes in fatty acid derivatives such as acyl-carnitines and eicosanoids. These methods are applied to assess lipid accumulation and composition.
How CRISPR Can Be Used to Study GO:1901568 fatty acid derivative metabolic process
Knockout
CRISPR knockout of genes such as CPT1A or ACADM can abolish fatty acid derivative metabolic process, allowing researchers to study loss-of-function phenotypes in cell models. Knockout cell lines are valuable for validating metabolic dependencies and drug targets.
Point Mutation
CRISPR point mutation can introduce specific amino acid changes in genes like ACADM to model patient mutations and assess their impact on enzyme activity and fatty acid oxidation. This approach helps distinguish pathogenic variants from benign polymorphisms.
Knock-in
CRISPR knock-in of tags (e.g., GFP) or reporter cassettes into endogenous loci such as CPT1A enables real-time tracking of protein localization and dynamics in fatty acid derivative metabolic process. Knock-in models can also introduce disease-relevant mutations.
Overexpression
CRISPR activation or lentiviral overexpression of genes like PPARA can enhance fatty acid derivative metabolic process, providing gain-of-function models to study metabolic regulation and potential therapeutic targets. Overexpression models are useful for identifying downstream effects on lipid metabolism.
How EDITGENE Supports fatty acid derivative metabolic process Research
Researchers studying fatty acid derivative metabolic process-related genes often need to determine whether a candidate gene is causally involved in metabolic phenotypes such as lipid accumulation, energy homeostasis, or disease progression. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for fatty acid derivative metabolic process research.
Frequently Asked Questions About fatty acid derivative metabolic process
What is GO:1901568 fatty acid derivative metabolic process?
GO:1901568 is a Gene Ontology biological process term defined as the chemical reactions and pathways involving fatty acid derivatives, including acyl-carnitines, acyl-CoAs, and related molecules.
What genes are involved in fatty acid derivative metabolic process?
Key genes include CPT1A, CPT1B, CPT2, ACADM, ACADVL, HADHA, HADHB, SLC25A20, PPARA, PPARG, and FABP1, among others.
How is fatty acid derivative metabolic process regulated?
It is regulated by substrate availability, malonyl-CoA inhibition of CPT1, hormonal signals, and transcriptional factors such as PPARA.
What diseases are associated with fatty acid derivative metabolic process?
Dysregulation is linked to non-alcoholic fatty liver disease, fatty acid oxidation disorders, and muscle bioenergetics defects.
What is the role of carnitine in fatty acid derivative metabolic process?
Carnitine is essential for the carnitine shuttle, which transports long-chain fatty acids into mitochondria for beta-oxidation.
How can CRISPR be used to study fatty acid derivative metabolic process?
CRISPR knockout, point mutation, knock-in, and overexpression can model gene function and identify causal roles in lipid metabolism.
What methods are used to study fatty acid derivative metabolic process?
Common methods include metabolic flux analysis, lipidomics, RNA-seq, proteomics, and CRISPR screens.
What is the connection between gut microbiota and fatty acid derivative metabolic process?
Gut commensals consuming host-accessible carbohydrates can influence fatty acid derivative metabolism and body mass regulation.
Can carnitine supplementation improve exercise performance?
Carnitine supplementation may improve physical exercise by enhancing muscle fatty acid oxidation, though effects depend on context.
What is mitochondrial lipid tolerance?
Mitochondrial lipid tolerance refers to the capacity of mitochondria to handle excess fatty acids without lipotoxicity, involving medium-chain ketothiolase flux.
Conclusion
GO:1901568 fatty acid derivative metabolic process is a central biological process that governs energy production, lipid signaling, and metabolic homeostasis. Its dysregulation contributes to prevalent diseases such as NAFLD and fatty acid oxidation disorders, making it a key area for therapeutic intervention. Advances in CRISPR-based models and metabolic profiling continue to unravel the complex regulation of this process, offering new opportunities for drug discovery and personalized medicine.
References
- 1. Gnoni A et al.. 2020. Carnitine in Human Muscle Bioenergetics: Can Carnitine Supplementation Improve Physical Exercise?. Molecules 25(1) PMID: 31906370
- 2. Adeva-Andany MM et al.. 2019. Mitochondrial β-oxidation of saturated fatty acids in humans.. Mitochondrion 46:73-90 PMID: 29551309
- 3. Wang S et al.. 2026. Hyperoside modulates bile acid and fatty acid metabolism, presenting a potentially promising treatment for non-alcoholic fatty liver disease.. J Adv Res 80:759-773 PMID: 40349961
- 4. Takeuchi T et al.. 2025. Acetylated cellulose suppresses body mass gain through gut commensals consuming host-accessible carbohydrates.. Cell Metab 37(8):1682-1697.e6 PMID: 40381616
- 5. Choi J et al.. 2024. Carnitine palmitoyltransferase 1 facilitates fatty acid oxidation in a non-cell-autonomous manner.. Cell Rep 43(12):115006 PMID: 39671290
- 6. Koves TR et al.. 2023. Pyruvate-supported flux through medium-chain ketothiolase promotes mitochondrial lipid tolerance in cardiac and skeletal muscles.. Cell Metab 35(6):1038-1056.e8 PMID: 37060901
